MX2007004004A - Vacunas multivalentes contra la influenza aviar. - Google Patents

Vacunas multivalentes contra la influenza aviar.

Info

Publication number
MX2007004004A
MX2007004004A MX2007004004A MX2007004004A MX2007004004A MX 2007004004 A MX2007004004 A MX 2007004004A MX 2007004004 A MX2007004004 A MX 2007004004A MX 2007004004 A MX2007004004 A MX 2007004004A MX 2007004004 A MX2007004004 A MX 2007004004A
Authority
MX
Mexico
Prior art keywords
avian influenza
strains
influenza vaccines
subtype
dose
Prior art date
Application number
MX2007004004A
Other languages
English (en)
Inventor
Mahesh Kumar
Juan Plana-Duran
Rut Villa-Quintana
Jordi Tarres-Call
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MX2007004004A publication Critical patent/MX2007004004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una composicion de vacuna y metodo que es efectivo en prevenir o aliviar la infeccion de Virus de Influenza Aviar se establece aqui. La vacuna contiene al menos dos cepas inactivas de virus de influenza aviar, en donde la 1 hemoaglutinina (HA) combinada total es al menos aproximadamente de 256 HA/dosis de la composicion de vacuna, y en donde cada una de las cepas presenta al menos aproximadamente 128 HA/dosis, y adicionalmente en donde una de las cepas tiene el mismo subtipo HA como aquel de un virus provocador, y en donde al menos una de las cepas tiene un subtipo NA diferente del virus provocador.
MX2007004004A 2004-10-07 2005-10-06 Vacunas multivalentes contra la influenza aviar. MX2007004004A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61670704P 2004-10-07 2004-10-07
US64845905P 2005-01-31 2005-01-31
PCT/US2005/035925 WO2006041978A2 (en) 2004-10-07 2005-10-06 Multivalent avian influenza vaccines

Publications (1)

Publication Number Publication Date
MX2007004004A true MX2007004004A (es) 2007-05-10

Family

ID=36148890

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004004A MX2007004004A (es) 2004-10-07 2005-10-06 Vacunas multivalentes contra la influenza aviar.

Country Status (17)

Country Link
US (1) US8067013B2 (es)
EP (1) EP1796720B1 (es)
JP (1) JP5105524B2 (es)
KR (1) KR101370464B1 (es)
CN (1) CN101035559B (es)
AP (1) AP2167A (es)
AR (1) AR051636A1 (es)
AU (1) AU2005294322A1 (es)
BR (1) BRPI0516542B1 (es)
CA (1) CA2581355C (es)
ES (1) ES2467094T3 (es)
MX (1) MX2007004004A (es)
MY (1) MY153290A (es)
NZ (1) NZ553975A (es)
TW (1) TWI365074B (es)
WO (1) WO2006041978A2 (es)
ZA (1) ZA200702876B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495139A (zh) * 2005-11-10 2009-07-29 迪娃解决方案股份有限公司 鉴别治疗组合物
US9072701B2 (en) * 2006-04-21 2015-07-07 St. Jude Children's Research Hospital Avian influenza viruses, vaccines, compositions, formulations, and methods
US20100098721A1 (en) * 2006-10-18 2010-04-22 St. Jude Children's Reseach Hospital Methods and compositions for preparing a universal influenza vaccine
CL2008000747A1 (es) * 2007-03-16 2008-04-25 Wyeth Corp Composicion de vacuna que comprende una primera y una segunda cepa inactivada del virus de la influenza aviar; metodo para vacunar un ave.
GB0810305D0 (en) * 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
WO2009156852A1 (en) 2008-06-25 2009-12-30 Novartis Ag Rapid responses to delayed booster immunisations
US8603548B2 (en) 2008-10-08 2013-12-10 Pokka Corporation Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent
EP3303571A4 (en) * 2015-06-04 2018-10-17 The University of Hong Kong Live-attenuated virus and methods of production and use
KR101964044B1 (ko) 2018-03-14 2019-04-02 인제대학교 산학협력단 재조합 아데노바이러스를 이용한 다가형 인플루엔자 생백신 플랫폼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US6159472A (en) * 1998-11-16 2000-12-12 Akzo Nobel N.V. Intradermal Avian immunization with inactivated vaccines
WO2003086453A1 (en) 2002-04-12 2003-10-23 Ilaria Capua Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

Also Published As

Publication number Publication date
TW200617166A (en) 2006-06-01
JP2008515906A (ja) 2008-05-15
ES2467094T3 (es) 2014-06-11
CN101035559A (zh) 2007-09-12
EP1796720B1 (en) 2014-04-23
AU2005294322A1 (en) 2006-04-20
CA2581355A1 (en) 2006-04-20
CA2581355C (en) 2016-01-26
JP5105524B2 (ja) 2012-12-26
BRPI0516542A (pt) 2008-09-09
TWI365074B (en) 2012-06-01
CN101035559B (zh) 2011-08-17
EP1796720A2 (en) 2007-06-20
AP2007003955A0 (en) 2007-07-30
KR20070059180A (ko) 2007-06-11
BRPI0516542B1 (pt) 2015-11-17
US8067013B2 (en) 2011-11-29
ZA200702876B (en) 2008-09-25
WO2006041978A2 (en) 2006-04-20
MY153290A (en) 2015-01-29
KR101370464B1 (ko) 2014-03-06
NZ553975A (en) 2010-04-30
AR051636A1 (es) 2007-01-31
US20060204976A1 (en) 2006-09-14
AP2167A (en) 2010-11-12
WO2006041978A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
MY153290A (en) Multivalent avian influenza vaccines
MX2022011671A (es) Vacunas contra el coronavirus y metodos de uso.
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
MX2009004223A (es) Protocolo de inmunizacion contra los 4 serotipos del dengue.
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ME00491B (me) Vakcina protiv bolesti zapadnog nila
ATE309821T1 (de) Influenzavirus-impfstoffzusammensetzung
WO2007095976A3 (de) Adjuvanz in form einer lipid-modifizierten nukleinsäure
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
NL300364I1 (nl) Recombinante influenzavirussen voor vaccins en gentherapie
WO2007057763A3 (en) Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant
MX2009006178A (es) Vacuna contra salmonela.
EP2078083A4 (en) NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR
MX351380B (es) Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
EP2066332A4 (en) INFLUENZA VACCINE COMPRISING A MIXTURE OF MANNANE AND ANTIGEN OF INFLUENZA
ATE547116T1 (de) Kombinationsimpfstoff
IL182440A0 (en) Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
MX2010006984A (es) Vacunas contra la malaria.
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
MX2023012530A (es) Composición y metodos de vacuna adyuvada.
WO2006024240A3 (es) Composición vacunal contra el virus de la hepatitis c.
WO2011074006A3 (en) Vaccine composition
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
BRPI0508660A (pt) composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status